
- Applied Clinical Trials-10-01-2020
- Volume 29
- Issue 10
The Future of Remote Trials
ACT's Editor-in-Chief, Lisa Henderson, assesses the sustainability of remote trials.
Let’s take a short vocabulary quiz. Full in-person, hybrid, virtual, remote, synchronous, asynchronous are terms used for, a) descriptions of clinical trials, b) types of cars, c) descriptions of learning models for schools during COVID-19. The answer is “c,” but the comparison I was going for is clearly trial design or type of site model. I left out decentralization because that would have been a huge giveaway, and I haven’t seen that term used yet on any school K-college curriculum. While I struggled with understanding synchronous and asynchronous as the two forms of online learning in the beginning, I have it down now. There has been a lot of discussion in clinical trials about the difference between virtual and remote, and I think that has been cleared up also. So let’s dive into the future of hybrid, decentralized, and remote trials.
According to a recent report from Frost & Sullivan,
The report also suggested that adoption of hybrid trials by CROs could increase their growth opportunities by enabling uninterrupted trials and cost savings of 15% to 20%; by focusing on long-term collaborations that offer substantial cost advantages with 8% to 13% savings across different trial phases; by leveraging new technologies, such as risk-based monitoring, eConsent, wearables, and telemedicine patient visits; and implementing direct-to-patient model clinical trial supplies
As we will explore in our
While I’m a supporter of remote and hybrid trials to support patients’ needs and expansion of availability of trials to more people, I have questions about the future of the same for long-time learning purposes. For the clinical research enterprise, the pandemic is bringing great innovation more quickly to an industry willing to move forward with purpose.
Lisa Henderson is Editor-in-Chief of Applied Clinical Trials. She can be reached at
Articles in this issue
almost 5 years ago
Better Cardiac Safety Trialsalmost 5 years ago
Applied Clinical Trials, October 2020 Issue (PDF)almost 5 years ago
Addressing the Needs of Clinical Trial Sites in a Post-COVID-19 Worldalmost 5 years ago
Shifting Perspectives on Site Networks to Create Positive Changealmost 5 years ago
News Notes (October)almost 5 years ago
When Trials Stumble, Mobile Research Nursing Lends a Helping Handalmost 5 years ago
Five Tips to Help Research Sites Implement Decentralized Clinical Trialsalmost 5 years ago
Europe's COVID Vaccine Bids Still Veiled in Secrecyalmost 5 years ago
COVID Advances Clinical Trial Transparencyalmost 5 years ago
COVID-19 Highlights Need for More Diversity in TrialsNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.